TOXICOGENOMICS OF ACETAMINOPHEN HEPATOTOXICITY- RECHALLENGE PROTOCOL
TOXICOGENOMICS OF ACETAMINOPHEN HEPATOTOXICITY- RECHALLENGE PROTOCOL
批准号:
7716907
负责人:
PAUL B WATKINS
金额:
$5.43万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-02 至 2008-05-31
关键词:
AcetaminophenAdmission activityBlood specimenComputer Retrieval of Information on Scientific Projects DatabaseDataDoseEnzymesFemaleFundingGene ExpressionGene Expression ProfileGrantHepatotoxicityHome environmentInstitutionLiverMonitorOutcomeParticipantPhysiologicalPlasmaProceduresProtocols documentationPurposeResearchResearch PersonnelResourcesSafetySerumSourceToxicogenomicsUnited States National Institutes of HealthUrineVisitWeekWomandayhealthy volunteerinterestmalemenmetabolomicsperipheral bloodresponsetranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Purpose: In this study, N=10 eligible normal healthy volunteers (5 men, 5 women) who have not been exposed to acetaminophen in the past six months will be admitted to the GCRC and challenged with acetaminophen (APAP: 1g Q6H for 10days). Then after avoiding APAP at home for two weeks these subjects will be re-admitted and re-challenged (1g Q6H for 10days). The outcomes of interest during each 10-day challenge are the maximum observed changes from baseline for the following responses: (1) serum log10ALT and other related liver enzymes, (2) gene expression indicated by peripheral blood transcriptome, (3) plasma metabolome profile, (4) urine metabolome profile.
The primary aim of the study is to evaluate correlation between the paired (challenge vs. rechallenge)liver enzyme responses. The expected result is that the subject s ALT response to rechallenge will be similar to his/her initial challenge response, thus yielding a high pair-wise
correlation. The secondary aims of the study are to explore physiologic responses indicated by the transcriptomic and metabolomic data.
Participants: Ten healthy subjects, five males and five females.
Procedures: Subjects will be admitted to the GCRC for 11 days and on day 1, they will begin dosing with acetaminophen. Blood samples will be taken throughout the protocol to monitor for safety and for research analyses. Once discharged, subjects will wait 14 days and then be
readmitted for identical study procedures as the first admission. There will be a followup visit at 14 days after discharge from the second admission and the study will then be completed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFECT OF ACETAMINOPHEN (TYLENOL) ON HUMAN LYMPHOCYTES
-
批准号:7716857
-
项目类别:
-
资助金额:$0.29万
-
财政年份:2008
-
负责人:PAUL B WATKINS
-
依托单位:
A MULTICENTER, LONGITUDINAL STUDY OF DRUG AND CAM INDUCED LIVER INJURY
-
批准号:7716801
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2008
-
负责人:PAUL B WATKINS
-
依托单位:
UNC Clinical Translation Science Award-K12 Scholars Program (KL2)
-
批准号:7620585
-
项目类别:
-
资助金额:$225.61万
-
财政年份:2008
-
负责人:PAUL B WATKINS
-
依托单位:
ACETAMINOPHEN (TYLENOL?) INDUCED HUMAN LYMPHOCYTE TOXICITY
-
批准号:7716902
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2008
-
负责人:PAUL B WATKINS
-
依托单位:
TOXICOGENOMICS OF ACETAMINOPHEN HEPATOTOXICITY
-
批准号:7716810
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2008
-
负责人:PAUL B WATKINS
-
依托单位:
UNC Clinical Translation Science Award-T32 Program (TL1)
-
批准号:7620629
-
项目类别:
-
资助金额:$16.78万
-
财政年份:2008
-
负责人:PAUL B WATKINS
-
依托单位:
ENVIRONMENTAL POLYMORPHISMS REGISTRY
-
批准号:7716780
-
项目类别:
-
资助金额:$1.19万
-
财政年份:2008
-
负责人:PAUL B WATKINS
-
依托单位:
ENVIRONMENTAL POLYMORPHISMS REGISTRY
-
批准号:7625555
-
项目类别:
-
资助金额:$14.22万
-
财政年份:2006
-
负责人:PAUL B WATKINS
-
依托单位:
EFFECT OF ACETAMINOPHEN (TYLENOL) ON HUMAN LYMPHOCYTES
-
批准号:7625656
-
项目类别:
-
资助金额:$0.51万
-
财政年份:2006
-
负责人:PAUL B WATKINS
-
依托单位:
GENE EXPRESSION AND ACETAMINOPHEN
-
批准号:7625594
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2006
-
负责人:PAUL B WATKINS
-
依托单位:
A MULTICENTER, LONGITUDINAL STUDY OF DRUG AND CAM INDUCED LIVER INJURY
-
批准号:7625580
-
项目类别:
-
资助金额:$0.77万
-
财政年份:2006
-
负责人:PAUL B WATKINS
-
依托单位:
ROLE OF CYTOCHROME P450 3A5 GENOTYPE UPON FLUCONAZOLE/MIDAZOLAM
-
批准号:7377425
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2005
-
负责人:PAUL B WATKINS
-
依托单位:
TOXICOGENOMICS OF ACETAMINOPHEN TOXICITY
-
批准号:7377487
-
项目类别:
-
资助金额:$1.86万
-
财政年份:2005
-
负责人:PAUL B WATKINS
-
依托单位:
A MULTICENTER, LONGITUDINAL STUDY OF DRUG AND CAM INDUCED LIVER INJURY
-
批准号:7377530
-
项目类别:
-
资助金额:$0.99万
-
财政年份:2005
-
负责人:PAUL B WATKINS
-
依托单位:
ENVIRONMENTAL POLYMORPHISMS REGISTRY
-
批准号:7377491
-
项目类别:
-
资助金额:$7.29万
-
财政年份:2005
-
负责人:PAUL B WATKINS
-
依托单位:
DRUG INDUCED LIVER INJURY NETWORK-IDIOSYNCRATIC LIVER INJURY
-
批准号:7377517
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2005
-
负责人:PAUL B WATKINS
-
依托单位:
ROLE OF CYTOCHROME P450 3A5 GENOTYPE UPON FLUCONAZOLE/MIDAZOLAM
-
批准号:7200220
-
项目类别:
-
资助金额:$0.47万
-
财政年份:2004
-
负责人:PAUL B WATKINS
-
依托单位:
A MULTICENTER, LONGITUDINAL STUDY OF DRUG AND CAM INDUCED LIVER INJURY
-
批准号:7200331
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2004
-
负责人:PAUL B WATKINS
-
依托单位:
GENETIC DATABASE FOR GENETIC POLYMORPHISMS IMPLICATED IN DRUG METABOLISM
-
批准号:7200219
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2004
-
负责人:PAUL B WATKINS
-
依托单位:
FC-FREE GRAPEFRUIT JUICE ON THE ORAL CLEARANCE OF FELODIPINE AND CYCLOSPORIN
-
批准号:7200231
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2004
-
负责人:PAUL B WATKINS
-
依托单位: